$1.03-0.11 (-9.65%)
Bluejay Diagnostics, Inc.
Bluejay Diagnostics, Inc. in the Healthcare sector is trading at $1.03 with a market capitalization of $5M. The stock is currently near its 52-week low of $1.02, remaining 71.7% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 30/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | β | β | β | β | β |
| Operating Income | -$1.94Mβ | -$1.46Mβ | -$1.62Mβ | -$1.99Mβ | -$1.89M |
| Net Income | -$1.92Mβ | -$1.43Mβ | -$1.60Mβ | -$1.96Mβ | -$1.86M |
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarke...
US equity futures were flat ahead of Thursday's opening bell as traders digested earnings from Pepsi
Gibo Holdings Ltd. 239,477,124 0.049